Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of grapefruit juice intake on etoposide bioavailability.
Reif S, Nicolson MC, Bisset D, Reid M, Kloft C, Jaehde U, McLeod HL. Reif S, et al. Eur J Clin Pharmacol. 2002 Oct;58(7):491-4. doi: 10.1007/s00228-002-0495-9. Epub 2002 Sep 3. Eur J Clin Pharmacol. 2002. PMID: 12389073 Clinical Trial.
Population pharmacokinetics of etoposide.
Reif S, Jetter A, Fuhr U, McLeod H, Kingreen D, Siegert W, Jaehde U. Reif S, et al. Int J Clin Pharmacol Ther. 2002 Dec;40(12):578-9. doi: 10.5414/cpp40578. Int J Clin Pharmacol Ther. 2002. PMID: 12503821 Clinical Trial. No abstract available.
Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [14C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers.
Gerisch M, Schwarz T, Lang D, Rohde G, Reif S, Genvresse I, Reschke S, van der Mey D, Granvil C. Gerisch M, et al. Among authors: reif s. Cancer Chemother Pharmacol. 2017 Sep;80(3):535-544. doi: 10.1007/s00280-017-3383-9. Epub 2017 Jul 11. Cancer Chemother Pharmacol. 2017. PMID: 28714036 Free PMC article.
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas.
Patnaik A, Appleman LJ, Tolcher AW, Papadopoulos KP, Beeram M, Rasco DW, Weiss GJ, Sachdev JC, Chadha M, Fulk M, Ejadi S, Mountz JM, Lotze MT, Toledo FG, Chu E, Jeffers M, Peña C, Xia C, Reif S, Genvresse I, Ramanathan RK. Patnaik A, et al. Among authors: reif s. Ann Oncol. 2016 Oct;27(10):1928-40. doi: 10.1093/annonc/mdw282. Ann Oncol. 2016. PMID: 27672108 Free PMC article. Clinical Trial.
365 results